Short answer
Incorporate advanced simulation and modeling techniques into the early stages of product development to predict outcomes and reduce the need for physical prototyping and testing.
- Field
- Innovation & Design
- Source
- International Journal of Health Sciences and Pharmacy (2022)
- Method
- Case Study
- Evidence
- Strong effect
Leveraging advanced simulation software can significantly reduce the need for extensive physical clinical trials in drug development. This innovation & design research insight is drawn from a 2022 study published in International Journal of Health Sciences and Pharmacy. Using Case study, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Incorporate advanced simulation and modeling techniques into the early stages of product development to predict outcomes and reduce the need for physical prototyping and testing.
Simcyp Software Accelerates Drug Development by Replacing 70% of Traditional Clinical Trials
Leveraging advanced simulation software can significantly reduce the need for extensive physical clinical trials in drug development.
International Journal of Health Sciences and Pharmacy · 2022
Key Findings
- 01Simcyp is a leading simulation software for model-based drug design and development.
- 02The software's strategy focuses on client satisfaction, delight, and enlightenment.
- 03Simulation can replace a significant portion of traditional clinical trials.
Application
Design takeaway
Incorporate advanced simulation and modeling techniques into the early stages of product development to predict outcomes and reduce the need for physical prototyping and testing.
How to apply
Explore and integrate simulation software relevant to your design domain to predict performance and user interaction before committing to physical prototypes.
Project actions
- 01When analyzing a product, consider its impact on the development lifecycle.
- 02Look for opportunities where digital tools can replace or augment physical testing.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Provides a real-world example of simulation's impact.
- +Analyzes the product using multiple established frameworks.
Limitations
The case study's findings are specific to the pharmaceutical industry and may not directly translate to all design fields. The analysis is based on available information, not direct user testing of the software.
Reliability & validity
The study's validity is based on the systematic application of analytical frameworks to existing information. Reliability is dependent on the consistency of the information sources used.
Think critically
To what extent can simulation software completely replace physical testing in product development, and what are the risks associated with over-reliance on virtual models?
Design Principles
"Embrace digital simulation to de-risk and accelerate physical product development."
This approach allows for faster iteration and testing of potential drug candidates, saving considerable time and resources. By modeling drug interactions and efficacy, designers and researchers can focus on the most promising avenues, leading to more efficient innovation cycles.
What This Means for Your Design
Using computer simulations can help design new drugs much faster and cheaper by testing them virtually instead of doing many real-life tests.
How to use in your project
- 1.Reference this study when discussing the benefits of simulation or modeling in your design process.
- 2.Use it to justify the use of digital tools to reduce the scope of physical testing in your design project.
Add to My Project
Quick Cite
Paragraph starter
The case study of Certara's Simcyp software highlights the significant potential of model-based simulation in accelerating product development, demonstrating how virtual testing can replace a substantial portion of traditional, time-consuming physical trials. This approach offers a pathway to more efficient innovation by allowing for rapid iteration and focused development on promising solutions, a principle applicable across various design disciplines.
Source
International Journal of Health Sciences and Pharmacy
Case Study on Certara’s Simcyp PBPK Simulator to Eliminate Lengthy Clinical Trails
journal · 2022
View sourceQuestions About This Research
- What does the research say about simcyp software accelerates drug development by replacing 70% of traditional clinical trials?
- Incorporate advanced simulation and modeling techniques into the early stages of product development to predict outcomes and reduce the need for physical prototyping and testing. Evidence: International Journal of Health Sciences and Pharmacy (2022).
- Why does "Simcyp Software Accelerates Drug Development by Replacing 70% of Traditional Clinical Trials" matter for design?
- This approach allows for faster iteration and testing of potential drug candidates, saving considerable time and resources. By modeling drug interactions and efficacy, designers and researchers can focus on the most promising avenues, leading to more efficient innovation cycles.
- How can designers apply this research?
- Incorporate advanced simulation and modeling techniques into the early stages of product development to predict outcomes and reduce the need for physical prototyping and testing.
- What were the main findings?
- Simcyp is a leading simulation software for model-based drug design and development.. The software's strategy focuses on client satisfaction, delight, and enlightenment.. Simulation can replace a significant portion of traditional clinical trials.
- What research method was used?
- Case Study.
- How strong is the evidence?
- Evidence strength is rated Strong effect, based on a 2022 journal from International Journal of Health Sciences and Pharmacy.
- What should I do differently in my next project?
- Explore and integrate simulation software relevant to your design domain to predict performance and user interaction before committing to physical prototypes.
- What are the limitations?
- The study relies on publicly available information and internal company strategies, which may not fully represent the complete picture of software implementation and client outcomes.